Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 Nov;3(6):769–773. doi: 10.1128/cdli.3.6.769-773.1996

Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation Group.

G J Gorse 1, E Y Yang 1, R B Belshe 1, P W Berman 1
PMCID: PMC170445  PMID: 8914773

Abstract

Salivary binding antibodies induced by candidate human immunodeficiency virus type 1 (HIV-1) vaccines in healthy, HIV-1 uninfected volunteers were assessed in a clinical trial evaluating intramuscularly injected HIV-1MN recombinant gp120 (rgp120) vaccine alone or with HIV-1IIIB rgp120 vaccine. The two rgp120 vaccines induced envelope glycoprotein-specific immunoglobulin G (IgG) and IgA antibodies in whole saliva and serum.

Full Text

The Full Text of this article is available as a PDF (178.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archibald D. W., Hebert C. A., Sun D., Tacket C. O. Salivary antibodies to human immunodeficiency virus type 1 in a phase I AIDS vaccine trial. J Acquir Immune Defic Syndr. 1990;3(10):954–958. [PubMed] [Google Scholar]
  2. Barrett N., Eder G., Dorner F. Characterization of a vaccinia-derived recombinant HIV-1 gp160 candidate vaccine and its immunogenicity in chimpanzees. Biotechnol Ther. 1991;2(1-2):91–106. [PubMed] [Google Scholar]
  3. Belshe R. B., Graham B. S., Keefer M. C., Gorse G. J., Wright P., Dolin R., Matthews T., Weinhold K., Bolognesi D. P., Sposto R. Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network. JAMA. 1994 Aug 10;272(6):475–480. doi: 10.1001/jama.272.6.475. [DOI] [PubMed] [Google Scholar]
  4. Berman P. W., Gregory T. J., Riddle L., Nakamura G. R., Champe M. A., Porter J. P., Wurm F. M., Hershberg R. D., Cobb E. K., Eichberg J. W. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature. 1990 Jun 14;345(6276):622–625. doi: 10.1038/345622a0. [DOI] [PubMed] [Google Scholar]
  5. Berman P. W., Matthews T. J., Riddle L., Champe M., Hobbs M. R., Nakamura G. R., Mercer J., Eastman D. J., Lucas C., Langlois A. J. Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1. J Virol. 1992 Jul;66(7):4464–4469. doi: 10.1128/jvi.66.7.4464-4469.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burnett P. R., VanCott T. C., Polonis V. R., Redfield R. R., Birx D. L. Serum IgA-mediated neutralization of HIV type 1. J Immunol. 1994 May 1;152(9):4642–4648. [PubMed] [Google Scholar]
  7. Cranage M. P., Baskerville A., Ashworth L. A., Dennis M., Cook N., Sharpe S., Farrar G., Rose J., Kitchin P. A., Greenaway P. J. Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus. Lancet. 1992 Feb 1;339(8788):273–274. doi: 10.1016/0140-6736(92)91335-6. [DOI] [PubMed] [Google Scholar]
  8. Forrest B. D. Mucosal approaches to HIV vaccine development. AIDS Res Hum Retroviruses. 1992 Aug;8(8):1523–1525. doi: 10.1089/aid.1992.8.1523. [DOI] [PubMed] [Google Scholar]
  9. Forrest B. D. Women, HIV, and mucosal immunity. Lancet. 1991 Apr 6;337(8745):835–836. doi: 10.1016/0140-6736(91)92527-9. [DOI] [PubMed] [Google Scholar]
  10. Fultz P. N., Nara P., Barre-Sinoussi F., Chaput A., Greenberg M. L., Muchmore E., Kieny M. P., Girard M. Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science. 1992 Jun 19;256(5064):1687–1690. doi: 10.1126/science.256.5064.1687. [DOI] [PubMed] [Google Scholar]
  11. Funkhouser A., Clements M. L., Slome S., Clayman B., Viscidi R. Antibodies to recombinant gp160 in mucosal secretions and sera of persons infected with HIV-1 and seronegative vaccine recipients. AIDS Res Hum Retroviruses. 1993 Jul;9(7):627–632. doi: 10.1089/aid.1993.9.627. [DOI] [PubMed] [Google Scholar]
  12. Gorse G. J., Rogers J. H., Perry J. E., Newman F. K., Frey S. E., Patel G. B., Belshe R. B. HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network. Vaccine. 1995 Feb;13(2):209–214. doi: 10.1016/0264-410x(95)93138-y. [DOI] [PubMed] [Google Scholar]
  13. Janoff E. N., Wahl S. M., Thomas K., Smith P. D. Modulation of human immunodeficiency virus type 1 infection of human monocytes by IgA. J Infect Dis. 1995 Sep;172(3):855–858. doi: 10.1093/infdis/172.3.855. [DOI] [PubMed] [Google Scholar]
  14. Kozlowski P. A., Black K. P., Shen L., Jackson S. High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. Masking by IgG. J Immunol. 1995 Jun 1;154(11):6163–6173. [PubMed] [Google Scholar]
  15. Kozlowski P. A., Chen D., Eldridge J. H., Jackson S. Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals. AIDS Res Hum Retroviruses. 1994 Jul;10(7):813–822. doi: 10.1089/aid.1994.10.813. [DOI] [PubMed] [Google Scholar]
  16. Marx P. A., Compans R. W., Gettie A., Staas J. K., Gilley R. M., Mulligan M. J., Yamshchikov G. V., Chen D., Eldridge J. H. Protection against vaginal SIV transmission with microencapsulated vaccine. Science. 1993 May 28;260(5112):1323–1327. doi: 10.1126/science.8493576. [DOI] [PubMed] [Google Scholar]
  17. McGhee J. R., Mestecky J., Dertzbaugh M. T., Eldridge J. H., Hirasawa M., Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine. 1992;10(2):75–88. doi: 10.1016/0264-410x(92)90021-b. [DOI] [PubMed] [Google Scholar]
  18. Mestecky J., Jackson S. Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines. J Clin Immunol. 1994 Sep;14(5):259–272. doi: 10.1007/BF01540979. [DOI] [PubMed] [Google Scholar]
  19. Miller C. J., McGhee J. R., Gardner M. B. Mucosal immunity, HIV transmission, and AIDS. Lab Invest. 1993 Feb;68(2):129–145. [PubMed] [Google Scholar]
  20. Muster T., Ferko B., Klima A., Purtscher M., Trkola A., Schulz P., Grassauer A., Engelhardt O. G., García-Sástre A., Palese P. Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J Virol. 1995 Nov;69(11):6678–6686. doi: 10.1128/jvi.69.11.6678-6686.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Peterman T. A., Curran J. W. Sexual transmission of human immunodeficiency virus. JAMA. 1986 Oct 24;256(16):2222–2226. [PubMed] [Google Scholar]
  22. Pomerantz R. J., de la Monte S. M., Donegan S. P., Rota T. R., Vogt M. W., Craven D. E., Hirsch M. S. Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann Intern Med. 1988 Mar;108(3):321–327. doi: 10.7326/0003-4819-108-3-321. [DOI] [PubMed] [Google Scholar]
  23. Schacker T., Collier A. C., Hughes J., Shea T., Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med. 1996 Aug 15;125(4):257–264. doi: 10.7326/0003-4819-125-4-199608150-00001. [DOI] [PubMed] [Google Scholar]
  24. Schwartz D. H., Gorse G., Clements M. L., Belshe R., Izu A., Duliege A. M., Berman P., Twaddell T., Stablein D., Sposto R. Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine. Lancet. 1993 Jul 10;342(8863):69–73. doi: 10.1016/0140-6736(93)91283-r. [DOI] [PubMed] [Google Scholar]
  25. Vasudevachari M. B., Uffelman K. W., Kovacs J., Yeh C. K., Lane H. C., Salzman N. P. Envelope-specific antibodies in the saliva of individuals vaccinated with recombinant HIV-1 gp160. J Acquir Immune Defic Syndr. 1992;5(8):817–821. [PubMed] [Google Scholar]
  26. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med. 1994 Aug 11;331(6):341–346. doi: 10.1056/NEJM199408113310601. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES